AI Strategy and Discovery
A hospital group in Chennai coordinated international patients through email, spreadsheets, and phone calls, and wanted to know whether AI could flag high-risk patients earlier. This work opens with a plain, sometimes uncomfortable look at whether the clinical data was genuinely ready to support that, before committing to a build. It usually takes one or two working sessions with the clinical team to get an honest answer either way.
- Data readiness and quality assessment before any commitment is made
- Use-case prioritization based on real institutional impact, not novelty
- Build-versus-buy analysis for off-the-shelf APIs versus custom models
- DPDP compliance mapping built into the roadmap from day one































